Search Results - "Aoshima, Keiji"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2
  3. 3

    Increased plasma levels of free tissue factor pathway inhibitor in patients with Graves' disease by Morishita, E, Hashimoto, T, Asakura, H, Saito, M, Yamazaki, M, Aoshima, K, Yoshida, T, Kato, H, Matsuda, T

    Published in Thrombosis and haemostasis (01-05-1998)
    “…Tissue factor pathway inhibitor (TFPI) is present in a free-form and in lipoprotein-associated forms in plasma. In this study, the plasma concentrations of…”
    Get more information
    Journal Article
  4. 4

    Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats by Yamazaki, M, Asakura, H, Aoshima, K, Saito, M, Jokaji, H, Uotani, C, Kumabashiri, I, Morishita, E, Ikeda, T, Matsuda, T

    Published in Thrombosis and haemostasis (1994)
    “…We investigated the protective effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against two kinds of experimental…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7

    Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases by Saito, M, Morishita, E, Asakura, H, Jokaji, H, Uotani, C, Kumabashiri, I, Yamazaki, M, Aoshima, K, Matsuda, T

    Published in Rinshō ketsueki (01-09-1996)
    “…We measured plasma levels of tissue factor (TF), total tissue factor pathway inhibitor (TFPI) and free TFPI antigen in patients with diabetes mellitus (DM),…”
    Get more information
    Journal Article
  8. 8

    Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rat models by Asakura, H, Aoshima, K, Suga, Y, Yamazaki, M, Morishita, E, Saito, M, Miyamoto, K, Nakao, S

    Published in Thrombosis and haemostasis (2001)
    “…1Alpha,25-dihydroxyvitamin D3 (active form of vitamin D3; vitamin D3) has been reported to induce the upregulation of thrombomodulin and downregulation of…”
    Get more information
    Journal Article
  9. 9

    Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus by Morishita, Eriko, Asakura, Hidesaku, Jokaji, Hiroshi, Saito, Masanori, Uotani, Chika, Kumabashiri, Ichiro, Yamazaki, Masahide, Aoshima, Keiji, Hashimoto, Takuma, Matsuda, Tamotsu

    Published in Atherosclerosis (01-02-1996)
    “…Diabetes mellitus is associated with disturbances in hemostasis that could contribute to the development of diabetic vascular disease. We investigated the…”
    Get full text
    Journal Article
  10. 10

    Plasma levels of lipoprotein(a) are elevated in patients with the antiphospholipid antibody syndrome by Yamazaki, M, Asakura, H, Jokaji, H, Saito, M, Uotani, C, Kumabashiri, I, Morishita, E, Aoshima, K, Ikeda, T, Matsuda, T

    Published in Thrombosis and haemostasis (01-04-1994)
    “…The mechanisms underlying clinical abnormalities associated with the antiphospholipid antibody syndrome (APAS) have not been elucidated. We measured plasma…”
    Get more information
    Journal Article
  11. 11

    Treatment of disseminated intravascular coagulation (DIC) with all-trans retinoic acid in an endotoxin-induced rat model by Aoshima, K, Asakura, H, Yamazaki, M, Saito, M, Kumabashiri, I, Morishita, E, Ontachi, Y, Mizutani, T, Ichino, T, Matsuda, T

    Published in Seminars in thrombosis and hemostasis (01-01-1998)
    “…Anticoagulant drugs such as heparin are often administered to patients with disseminated intravascular coagulation (DIC) who are also being treated for their…”
    Get more information
    Journal Article
  12. 12

    Prothrombin Fragment 1 +2 Measures Treatment Effect in Patients with Antiphospholipid Syndrome by Yamazaki, Masahide, Asakura, Hidesaku, Saito, Masanori, Jokaji, Hiroshi, Uotani, Chika, Kumabashiri, Ichiro, Morishita, Eriko, Aoshima, Keiji, Matsuda, Tamotsu, Triplett, Douglas A.

    Published in Thrombosis research (01-08-1998)
    “…Antiphospholipid syndrome (APS) is characterized by recurrent thrombosis. The anticoagulant management of APS thrombosis remains controversial. Few reports on…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Haemostatic and fibrinolytic parameters in septic patients with leukopenia or leukocytosis by Saito, M, Asakura, H, Jokaji, H, Uotani, C, Kumabashiri, I, Morishita, E, Yamazaki, M, Yoshida, T, Aoshima, K, Matsuda, T

    Published in European journal of haematology (01-03-1995)
    “…Induction of leukocytopenia by cytotoxic drugs protects against the generalized Shwartzman reaction induced by endotoxin. To elucidate the relationship between…”
    Get more information
    Journal Article
  15. 15